LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 1,867 -83.00 (-4.26%) As of 05:54 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesNews and Trends About Bioventix Stock (LON:BVXP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bioventix alerts:Sign Up Key Stats Today's Range 1,850▼ 1,99050-Day Range 1,477▼ 2,05452-Week Range 1,300▼ 2,255Volume18,149 shsAverage Volume12,539 shsMarket Capitalization£97.55 millionP/E Ratio13.00Dividend Yield7.41%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVXP Stock News HeadlinesBioventix : Posting of Annual Report and Notice of AGMNovember 6 at 5:11 PM | marketscreener.comMBioVentix Posts Marginal Increase In FY26 Profit Before Tax; Shares DropOctober 28, 2026 | rttnews.comMy prediction for December 8thElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 9 at 1:00 AM | Behind the Markets (Ad)Bioventix (AIM:BVXP) Stock FY Results Keep Margins Strong Dividend Questions OpenOctober 27, 2026 | finance.yahoo.comBioventix PLC Reports Earnings Results for the Full Year Ended June 30, 2026October 26, 2026 | marketscreener.comMBioventix Reports £13 Million Annual Revenue and £10.2 Million Pre-Tax Profit as Neurology Royalties IncreaseOctober 26, 2026 | uk.finance.yahoo.comErgebnis-Flash (BVXP.L) Bioventix plc meldet Umsatz von 13,0 Mio. GBP im Geschäftsjahr 2026October 26, 2026 | de.marketscreener.comDDown 43% with a 9% dividend yield – should I buy this stock?June 7, 2026 | uk.finance.yahoo.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 1,905 at the start of the year. Since then, BVXP stock has increased by 2.4% and is now trading at GBX 1,950. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) issued its quarterly earnings results on Monday, October, 26th. The biotechnology company reported GBX 145.74 earnings per share for the quarter. The biotechnology company earned £12.97 million during the quarter. Bioventix had a net margin of 58.70% and a trailing twelve-month return on equity of 67.81%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include PayPal (PYPL), ServiceNow (NOW), Ameriwest Lithium (AWLID), Berkshire Hathaway (BRK.B), Capital One Financial (COF), Salesforce (CRM) and Alpha FX Group (AFX). Company Calendar Last Earnings10/26/2026Today11/09/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 143.62 Trailing P/E Ratio13.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£8.12 million Net Margins58.70% Pretax MarginN/A Return on Equity67.81% Return on Assets54.07% Debt Debt-to-Equity Ratio0.10 Current Ratio8.53 Quick Ratio5.50 Sales & Book Value Annual Sales£12.97 million Price / Sales7.52 Cash FlowGBX 60.44 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book8.12Miscellaneous Outstanding Shares5,225,000Free FloatN/AMarket Cap£97.55 million OptionableNot Optionable Beta0.54 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (LON:BVXP) was last updated on 11/9/2026 by MarketBeat.com Staff. From Our PartnersTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredTesla pays zero dividends but this new fund pays monthlyTesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe IRS loophole Trump fought to preserve for retirees401(k) balances have reached record highs on a rising stock market and strong job growth. But traditional acco...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVXP Stock Alerts